New Nomenclature for Sphincter of Oddi Dysfunction
The traditional classification of Sphincter of Oddi dysfunction (SOD) types 1-3 has been replaced by the Rome IV criteria, which now uses the terms "Functional Biliary Sphincter Disorder" (FBSD) for what was previously SOD types I and II, while the former SOD type III has been discarded entirely as a valid clinical entity 1.
Understanding the Nomenclature Change
The Rome IV criteria fundamentally restructured how we conceptualize these disorders based on evidence showing that the old type III SOD classification was not a legitimate diagnosis:
What Happened to Each Type:
Former SOD Type I (biliary pain + elevated liver enzymes + dilated bile duct): Now classified as Functional Biliary Sphincter Disorder (FBSD) with objective findings 1
Former SOD Type II (biliary pain + either elevated enzymes OR dilated duct): Now also classified as Functional Biliary Sphincter Disorder (FBSD) with some objective findings 1
Former SOD Type III (biliary pain alone without objective abnormalities): This classification has been eliminated - these patients should not undergo ERCP-based interventions 1
Why the Change Occurred
The reclassification was driven by rigorous evidence, particularly a landmark sham-controlled study demonstrating that sphincterotomy provided no benefit over placebo in patients with post-cholecystectomy pain and minimal objective abnormalities (the old type III category) 1. This finding was so definitive that ERCP approaches are no longer considered appropriate for this patient population 1.
Clinical Implications
For patients with objective biliary obstruction findings (former types I and II, now FBSD): Current evidence supports biliary sphincterotomy, though practitioners must weigh this against post-procedure pancreatitis rates of 10-15% 2. These patients may benefit from endoscopic intervention 3, 4.
For patients with pain alone and no objective findings (former type III): These patients have functional complaints or psychosocial disabilities requiring only medical management - not endoscopic intervention 3. Attempting sphincterotomy in this population exposes patients to significant procedural risk without demonstrated benefit.
Important Caveats
The term "Functional Gallbladder Disorder" (FGBD) is distinct and refers to gallbladder dysfunction in patients with an intact gallbladder, not sphincter of Oddi pathology 1. Don't confuse FBSD (sphincter) with FGBD (gallbladder).
The evidence base for FBSD treatment remains limited, with an acknowledged need for additional randomized sham/placebo-controlled trials for both pharmacological and non-pharmacological treatments 2.